| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. | J Natl Cancer Inst | 1998 | 5.30 |
| 2 | Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses. | Nat Med | 1999 | 2.42 |
| 3 | Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study. | J Neurosurg | 2000 | 1.06 |
| 4 | Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector. | Gene Ther | 1998 | 1.04 |
| 5 | Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade. | J Neuropathol Exp Neurol | 1999 | 0.98 |
| 6 | Osteoclast abnormalities in fractured bone during bisphosphonate treatment for osteoporosis: a case report. | Skeletal Radiol | 2012 | 0.87 |